Supernus Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI
Full Sustainability assessment of Supernus Pharmaceuticals Inc are reached by registering for free. This article includes a questions and answers table for Supernus Pharmaceuticals Inc. This Sustainability rating for Supernus Pharmaceuticals Inc represents the company's reporting of the United Nations SDGs.
Supernus Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 4.0, social score of 4.8 and governance score of 8.0.
5.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 579 | Tonix Pharmaceuticals Holding Corp | 5.7 | High |
| 579 | VIVA Biotech Holdings | 5.7 | High |
| 602 | Supernus Pharmaceuticals Inc | 5.6 | High |
| 602 | Celltrion Inc | 5.6 | High |
| 602 | Adaptimmune Therapeutics PLC | 5.6 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Supernus Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Supernus Pharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Supernus Pharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Supernus Pharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Supernus Pharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Supernus Pharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Supernus Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy treatment of partial onset epilepsy seizures in adults and children between 6 to 17 years of age. The company's commercial products also comprise Qelbree, a selective norepinephrine reuptake inhibitor indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients 6 to 17 years of age; APOKYN for the acute intermittent treatment of hypomobility or off episodes in patients with advanced Parkinson's Disease (PD); XADAGO for treating levodopa/carbidopa in patients with PD experiencing off episodes; MYOBLOC, a Type B toxin product indicated for the treatment of cervical dystonia and sialorrhea in adults; GOCOVRI for the treatment of dyskinesia in patients with PD; and Osmolex ER for the treatment of Parkinson's disease and drug-induced extrapyramidal reaction in adult patients. In addition, its product candidates include Qelbree (SPN-812), which has completed Phase III clinical trials that is used for the treatment of ADHD; SPN-830, a late-stage drug/device combination product candidate for the prevention of off episodes in PD patients; SPN-817, a novel product candidate in Phase I clinical trials for the treatment of severe epilepsy; SPN-820, a product candidate in Phase II clinical trials for treating resistant depression; and SPN-443 and SPN-446, which are in preclinical stage for treating CNS. The company markets and sells its products through pharmaceutical wholesalers, specialty pharmacies, and distributors. The company was incorporated in 2005 and is headquartered in Rockville, Maryland.